Your participation can help us learn more about preventing severe or acute illness from RSV
Find out today if the VANIR Study is right for you!
Respiratory Syncytial Virus, or RSV, is a common yet highly infectious virus that can cause severe or acute respiratory illness, especially in older adults.
If you are concerned about severe or acute respiratory illness from RSV, there may be something you can do. Consider taking part in the VANIR Study of a new investigational vaccine called MVA-BN-RSV that aims to protect older adults from getting seriously ill from RSV.
Participating in the VANIR Study may help protect you from severe or acute respiratory illness from RSV, although there is no guarantee the study vaccine will work. The study will also help doctors learned more about the study vaccine and how it works, which may help prevent severe or acute respiratory infection from RSV in the future.
You may be able to join the VANIR Study if you:
· Are 60 years of age or older
· Are healthy or have one or more chronic medical conditions, including mild to moderate underlying illnesses such as chronic cardiac diseases, lung disease, congestive heart failure, hypertension, and type 2 diabetes mellitus
· Are willing and able to use a smartphone or tablet application to record information during the study
Other criteria will need to be met to confirm your eligibility for this study.